Evolutionary Genomics

Evolutionary Genomics Share Buybacks

Share Buybacks of Evolutionary Genomics (FNAM) as of Oct 26, 2026.

Share Buybacks

0.00USD

Last updated:

Share Buybacks of Evolutionary Genomics is 2018 0.00 USD. Share Buybacks of Evolutionary Genomics was 2017 0.00 USD. It decreases by % lower compared to the previous year.

The Evolutionary Genomics Share Buybacks history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Share Buybacks
Date
Share Buybacks
Jan 1, 2014
2.04 M USD
Jan 1, 2015
1.23 M USD
Jan 1, 2016
1.29 M USD
Jan 1, 2017
0.00 USD
Jan 1, 2018
0.00 USD
The Evolutionary Genomics Share Buybacks history
YEARShare BuybacksYoY
0.00USD—
0.00USD-100.00%
1.29 MUSD+5.24%
1.23 MUSD-39.71%
2.04 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Evolutionary Genomics Stock analysis

What does Evolutionary Genomics do? Evolutionary Genomics, Inc. generates revenue through the identification and validation of genes impacting commercially valuable traits in crops for the agriculture industry. The company utilizes its Adapted Traits Platform (ATP) to identify genes that control important traits in plants and animals, focusing on yield increases in corn and rice, drought tolerance, sugar content in tomatoes, and pest/disease resistance in soybeans, cassava, beans, tomatoes, and cotton. The firm applies ATP in research projects for agricultural clients seeking improved crop performance. The company targets agricultural industry clients who require gene-based solutions for enhancing crop traits such as yield, drought tolerance, and pest resistance. The Adapted Traits Platform (ATP) is central to the company's product offering, enabling throughput molecular evolution analysis through non-synonymous site (Ka) and synonymous site (Ks) analysis to identify positively selected genes. This platform identifies genes that have successfully adapted to impart new or improved traits in agricultural crops. The firm's research projects include specific applications like yield increases in corn and rice, drought tolerance in crops, and pest resistance in soybeans, cassava, beans, tomatoes, and cotton. Agricultural companies and research institutions are the primary buyers of these gene identification services. Evolutionary Genomics, Inc. focuses on the agriculture industry, specifically targeting clients who need gene validation for crop improvement. The company's services are used to identify genes responsible for commercially valuable traits such as yield, drought tolerance, and pest resistance. The firm's ATP platform is applied in research projects for crops including corn, rice, soybeans, cassava, beans, tomatoes, and cotton. Agricultural clients seeking to enhance their crop traits through gene-based solutions are the key market segment for the company's offerings. Evolutionary Genomics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Evolutionary Genomics stock

On Eulerpool you can find the complete historical development of Share Buybacks Evolutionary Genomics since 2006 – with annual values, charts, and detailed analysis.

Share buybacks represent the cash spent repurchasing the company's own shares. Buybacks reduce shares outstanding and can increase EPS.

Share Buybacks's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Share Buybacks's Evolutionary Genomics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Evolutionary Genomics

All Key Metrics — Evolutionary Genomics